NOTCH1 and B-cell chronic lymphocytic leukemia: Interestingly, some aberrations may be predictive in certain specific contexts only, such as the proposed resistance of NOTCH1-mutated CLL to treatment with rituximab and ofatumumab, but this observation requires further validation before NOTCH1 status should be used to guide treatment choice.